Annual report pursuant to Section 13 and 15(d)

Fair Value Measurement (Tables)

v3.22.0.1
Fair Value Measurement (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value Measurement  
Schedule of financial instruments measured at fair value on recurring basis

As of December 31, 2021

Quoted Market

Prices in Active

Significant

Markets for

Significant Other

Unobservable

Identical Assets

Observable Inputs

 Inputs

Total Fair Value 

(in thousands)

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Measurements

Assets:

  

  

  

  

Cash equivalents:

$

12,324

$

$

$

12,324

Liabilities:

 

  

 

  

 

  

 

  

Contingent consideration current

 

 

 

1,717

 

1,717

Contingent consideration non‑current

 

 

 

 

Contingent consideration

$

$

$

1,717

$

1,717

As of December 31, 2020

Quoted Market

Prices in Active

Significant 

Markets for

Significant Other

Unobservable

Identical Assets

Observable Inputs

 Inputs

Total Fair Value 

(in thousands)

    

(Level 1)

    

(Level 2)

    

(Level 3)

    

Measurements

Assets:

  

  

  

  

Cash equivalents:

$

2,474

$

$

$

2,474

Liabilities:

 

  

 

  

 

  

 

  

Contingent consideration current

 

 

 

1,198

 

1,198

Contingent consideration non‑current

 

 

 

462

 

462

Contingent consideration

$

$

$

1,660

$

1,660

Schedule of fair value measurements of the contingent consideration categorized with Level 3

(in thousands)

    

Balance as of January 1, 2019

$

Fair value at date of acquisition

4,689

Fair value adjustments

(1,079)

Payments during the year

(601)

Accretion expense

201

Balance as of December 31, 2019

    

$

3,210

Fair value adjustments

 

(949)

Payments during the year

 

(601)

Balance as of December 31, 2020

$

1,660

Fair value adjustments

 

57

Payments during the year

 

Balance as of December 31, 2021

$

1,717